Cargando…
Oral Vaccine Delivery for Intestinal Immunity—Biological Basis, Barriers, Delivery System, and M Cell Targeting
Most currently available commercial vaccines are delivered by systemic injection. However, needle-free oral vaccine delivery is currently of great interest for several reasons, including the ability to elicit mucosal immune responses, ease of administration, and the relatively improved safety. This...
Autores principales: | Kang, Sung Hun, Hong, Seok Jin, Lee, Yong-Kyu, Cho, Sungpil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403562/ https://www.ncbi.nlm.nih.gov/pubmed/30960873 http://dx.doi.org/10.3390/polym10090948 |
Ejemplares similares
-
Antibody-mediated oral delivery of therapeutic DNA for type 2 diabetes mellitus
por: Cha, Seungbin, et al.
Publicado: (2018) -
Oral Delivery of Biologics via the Intestine
por: New, Roger
Publicado: (2020) -
Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier
por: Coria, Lorena M., et al.
Publicado: (2019) -
Intestinal mucoadhesive devices for oral delivery of insulin
por: Banerjee, Amrita, et al.
Publicado: (2016) -
Systemic and mucosal immune responses following oral adenoviral delivery of influenza vaccine to the human intestine by radio controlled capsule
por: Kim, Leesun, et al.
Publicado: (2016)